The Institute of Clinical Research (ICR) is continuing its work to promote understanding and raise standards in clinical research with the publication of a new book on the EU Directives.
The Pocket Guide to the EU Directives for Clinical Research provides a summary of the key aspects of the Clinical Trials Directive 2001/20/EC, Good Clinical Practice Directive 2005/28/EC and Good Manufacturing Practice Directive 2003/94/EC. The publication is designed to be read in conjunction with the Directives themselves and provides a useful, easy to read overview.
This compact guide is written by Dr Julie Meeson FICR, a quality assurance consultant who also runs her own company providing quality assurance and training services to pharmaceutical companies and CROs. Julie commented "The EU Directives are critical documents for all clinical research professionals but can be difficult for many to understand.
"The three Directives cover the most extensive changes in European Union clinical trial legislation and our new book will help clinical research professionals better understand and use the Directives in their work."
Another recent addition to the ICR's extensive range of clinical research booklets and monographs is The ICR Guide to Freelancing, which highlights the benefits and pitfalls of freelancing and provides useful tips for starting out on your own.
For corporate and bulk purchases, the ICR can provide ICH GCP and Fundamental Guidelines booklets with customised covers, which can be distributed to staff as part of their continuing professional development or during training courses.
The Pocket Guide to the EU Directives for Clinical Research (ISBN: 9 781905 238675) is priced at £17.00 and is available for purchase via the online shop or from other online booksellers. For further information log on to the ICR website at www.icr-global.org/resources/publications/.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.